scholarly journals Stable isotope-labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults

2016 ◽  
Vol 81 (2) ◽  
pp. 235-245 ◽  
Author(s):  
Ronald de Vries ◽  
Johan W. Smit ◽  
Peter Hellemans ◽  
James Jiao ◽  
Joseph Murphy ◽  
...  
1999 ◽  
Vol 43 (12) ◽  
pp. 3005-3007 ◽  
Author(s):  
Melinda K. Lacy ◽  
David P. Nicolau ◽  
Charles H. Nightingale ◽  
Amy Geffken ◽  
Renli Teng ◽  
...  

ABSTRACT Trovafloxacin pharmacokinetics were evaluated in 12 subjects with AIDS. By using a randomized design, single 200-mg doses of oral trovafloxacin and intravenous alatrofloxacin were administered. The mean absolute bioavailability was 91%. The pharmacokinetics of trovafloxacin when administered orally as the active form or intravenously as the prodrug (alatrofloxacin) are not altered in subjects with AIDS compared to those in healthy adults.


2017 ◽  
Vol 65 (14) ◽  
pp. 3006-3012 ◽  
Author(s):  
Melissa M. Melough ◽  
Terrence M. Vance ◽  
Sang Gil Lee ◽  
Anthony A. Provatas ◽  
Christopher Perkins ◽  
...  

1982 ◽  
Vol 35 (4) ◽  
pp. 647-654 ◽  
Author(s):  
M Janghorbani ◽  
M J Christensen ◽  
A Nahapetian ◽  
V R Young

2018 ◽  
Vol 8 (2) ◽  
pp. 198-207 ◽  
Author(s):  
Karthick Vishwanathan ◽  
Karen So ◽  
Karen Thomas ◽  
Alex Bramley ◽  
Stephen English ◽  
...  

2015 ◽  
Vol 20 (2) ◽  
pp. 105-111
Author(s):  
Alexander Toledo ◽  
Christopher S. Amato ◽  
Nigel Clarke ◽  
Richard E. Reitz ◽  
David Salo

BACKGROUND: The injectable formulation of dexamethasone has been administered orally, for the treatment of pediatric asthma and croup. The practice is followed in emergency departments around the country, but pharmacokinetic data supporting this practice are lacking. OBJECTIVES: This study evaluated the relative bioavailability and pharmacokinetics of dexamethasone sodium phosphate for injection (DSPI) administered orally compared to dexamethasone oral concentrate (DOC) in healthy adults. METHODS: This was an open label, crossover study of 11 healthy adults 18 to 45 years of age. All subjects received 8 mg of dexamethasone oral concentrate initially. After a 1-week wash-out period, subjects received 8 mg of DSPI administered orally. Dexamethasone levels were measured by liquid chromatography in tandem mass spectrometry. Cmax and area under the curve (AUC (0-t) and AUC (0-∞)) were calculated and compared between groups using the paired t test. RESULTS: The mean ± SD AUC(0-t) for dexamethasone oral concentrate and DSPI were 5497.23 ± 1649 and 4807.82 ± 1971) ng/dL/hr, respectively; 90% confidence interval (CI) was 78.8%–96.9%. The mean ± SD AUC(0-∞) for dexamethasone oral concentrate and DSPI were 6136.43 ± 2577 and 5591.48 ± 3075 ng/dL/hr, respectively; 90% CI was 79.0% –105.2%. Mean Cmax ± SD for DOC and DSPI were 942.94 ± 151 and 790.92 ± 229 ng/dL, respectively; 90% CI 76.8%–91.7%. The relative bioavailability of DSPI administered orally was 87.4% when using AUC(0-t) and 91.1% when using AUC(0-∞). The calculated absolute bioavailability was 75.9%. CONCLUSIONS: DSPI is not bioequivalent to dexamethasone oral concentrate when administered orally. The existing literature supports the efficacy of DSPI despite this. Dosing adjustments may be considered.


1975 ◽  
Vol 18 (5part1) ◽  
pp. 613-622 ◽  
Author(s):  
John M. Strong ◽  
John S. Dutcher ◽  
Woong-Ku Lee ◽  
Arthur J. Atkinson

2014 ◽  
Vol 52 (11) ◽  
pp. 957-964 ◽  
Author(s):  
Christoph Markert ◽  
Theresia Wirsching ◽  
Regina Hellwig ◽  
Jürgen Burhenne ◽  
Johanna Weiss ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document